April 28, 2023 by admin aurigene Potent anti-tumor activity of AUR102, a selective covalent inhibitor of CDK7
April 28, 2023 by admin aurigene Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies | ACS Medicinal Chemistry Letters
April 28, 2023 by admin aurigene Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase
April 28, 2023 by admin aurigene Peptide and peptide-inspired checkpoint inhibitors: Protein fragments to cancer immunotherapy
April 28, 2023 by admin aurigene PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
April 28, 2023 by admin aurigene Orally bioavailable SMARCA2 degraders with exceptional selectivity and potency
April 28, 2023 by admin aurigene Evaluation of AU-18069, a novel small molecule CBP/p300 bromodomain inhibitor for the treatment of cancers
April 28, 2023 by admin aurigene Novel, potent and orally bioavailable small molecule CD73 inhibitors for cancer immunotherapy
